Healthcare Venture Fund - Venture Capital |

Healthcare Venture Fund

The Healthcare Venture Fund invests in transformative Canadian companies that will dramatically increase healthcare productivity by reducing healthcare costs while improving patient health.

Our experienced team manages $270 million in capital across two different funds. The team is currently seeking investments in the drug, devices, diagnostics and digital health sectors.

Are you seeking funding for your transformative company?

Please send us your business plan at

Latest news

April 11, 2016

Profound Medical Corp., receives CE Mark Approval for TULSA-PRO™

Profound Medical Corp. (“Profound” or “Company”) (TSXV:PRN), a medical device company commercializing a unique and minimally invasive therapy in prostate care, today announced that the company has received CE Mark approval for the commercial sale of TULSA-PROTM.

View all news

June 15, 2015

Milestone Pharmaceuticals Closes US$17 Million Series B Financing to Complete Phase 2 Clinical Studies for MSP-2017

Milestone Pharmaceuticals Inc., a clinical stage cardiovascular company in Phase 2, today announced the close of a US$17 million Series B financing.